Volume activated anion channel and astrocytic cellular edema in traumatic brain injury and stroke

Advances in Experimental Medicine and Biology

Volumn 559, Issue , 2005, Pages 157-167

  Kimelberg, Harold K ^a  

^a ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION CHANNEL;

ANION TRANSPORT; ASTROCYTE; CAT; CONFERENCE PAPER; NONHUMAN; PRIORITY JOURNAL; STROKE; TRAUMATIC BRAIN INJURY;

EID: 33646877269     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-23752-6_15     Document Type: Conference Paper

References (46)

1. O. Devuyst and W.B. Guggino, Chloride channels in the kidney: lessons learned from knockout animals, Am. J. Physiol Renal Physiol. 283, F1176-F1191 (2002).
2. + channel in human erythrocytes, Int. J. Biochem. Cell Biol. 35, 1182-1197 (2003).
3. P. Calabresi, L.M. Cupini, D. Centonze, F. Pisani and G. Bernardi, Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia, Ann. Neurol. 53, 693-702 (2003).
4. B. Nilius and G. Droogmans, Amazing chloride channels: an overview, Acta Physiol Scand. 177, 119-147 (2003).
5. B. Nilius, J. Eggermont, T. Voets, G. Buyse, V. Manolopoulos and G. Droogmans, Properties of volume-regulated anion channels in mammalian cells, Prog. Biophys. Mol. Biol. 68, 69-119 (1997).
6. T.J. Jentsch, V. Stein, F. Weinreich and A.A. Zdebik, Molecular structure and physiological function of chloride channels, Physiol Rev. 82, 503-568 (2002).
7. K. Strange, F. Emma and P.S. Jackson, Cellular and molecular physiology of volume-sensitive anion channels, Am. J. Physiol. Cell Physiol. 270, C711-C730 (1996).
8. K. Tuz, B. Ordaz, L. Vaca, O. Quesada and H. Pasantes-Morales, Isovolumetric regulation mechanisms in cultured cerebellar granule neurons, J. Neurochem. 79, 143-151 (2001).
9. M.E. Chamberlin and K. Strange, Anisosmotic cell volume regulation: a comparative view, Am. J. Physiol. 257, C159-C173 (1989).
10. L.R. Nelson, R.S. Bourke, A.J. Popp, J. Cragoe, A. Signorelli, V.V. Foster and W. Creel, Evaluation of treatment modalities in severe head injuries using an animal model, in "Neural Trauma" (A.J. Popp, R.S. Bourke, L.R. Nelson and H.K. Kimelberg, Eds.), Raven Press, New York (1979).
11. R. Bullock, W.L. Maxwell, D.I. Graham, G.M. Teasdale and J.H. Adams, Glial swelling following cerebral contusion: an ultrastructural study, J. Neurology, Neurosurgery and Psychiatry 54, 427-434 (1991).
12. K.D. Barron, M.P. Dentinger, H.K. Kimelberg, L.R. Nelson, R.S. Bourke, S. Keegan, R. Mankes and E.J. Cragoe, J., Ultrastructural features of a brain injury model in cat. I. Vascular and neuroglial changes and the prevention of astroglial swelling by a fluorenyl (aryloxy) alkanoic acid derivative (L-644, 711), Acta Neuropathol. (Berl.) 75, 295-307 (1988).
13. Y. Matsushita, K. Shima, H. Nawashiro and K. Wada, Real-time monitoring of glutamate following fluid percussion brain injury with hypoxia in the rat, J. Neurotrauma 17, 143-153 (2000).
14. E.J. Cragoe, Jr, Drugs for the treatment of traumatic brain injury, Med. Res. Rev. 7, 271-305 (1987).
15. E.J. Cragoe, Jr, N.P. Gould, O.W. Woltersdorf, Jr, C. Ziegler, R.S. Bourke, L.R. Nelson, H.K. Kimelberg, J.B. Waldman, A.J. Popp and N. Sedransk, Agents for the treatment of brain injury. 1. (Aryloxy)alkanoic acids, J. Med. Chem. 25, 567-579 (1982).
16. E.J. Cragoe, Jr, O.W. Woltersdorf, Jr, N.P. Gould, A.M. Pietruszkiewicz, C. Ziegler, Y. Sakurai, G.E. Stokker, P.S. Anderson, R.S. Bourke, H.K. Kimelberg, L.R. Nelson, K.D. Barron, J.E. Rose, D. Szarowski, A.J. Popp and J.B. Waldman, Agents for the treatment of brain edema. 2. [2,3,9,9a-Tetrahydro-3- oxy-substituted-1 H-fluoren-7-yl) oxyalkanoic acids and some of their analogues, J. Med. Chem. 29, 825-841 (1986).
17. H.K. Kimelberg, J.W. Rose, K.D. Barron, R.A. Waniewski and E.J. Cragoe, Jr, Astrocytic swelling in head injury: beneficial effects of an inhibitor of anion exchange transport and glutamate uptake in glial cells, Molec. Chem. Neuropathol. 11, 1-31 (1989).
18. H.K. Kimelberg, E.J. Cragoe, Jr, L.R. Nelson, A.J. Popp, D. Szarowski, J.W. Rose, O.W. Woltersdorf, Jr and A.M. Pietruszkiewicz, Improved recovery from a traumatic-hypoxic brain injury in cats by intracisternal injection of an anion transport inhibitor, Cent. Nerv. Syst. Trauma. 4, 3-14 (1987).
19. J.H. Garcia, H. Kalimo, Y. Kamijyo and B.F. Trump, Cellular events during partial cerebral ischemia. I. Electron microscopy of feline cerebral cortex after middle-cerebral-artery occlusion, Virchow's Arch. B Cell Path. 25, 191-206 (1977).
20. K.F. Liu, F.H. Li, T. Tatlisumak, J.H. Garcia, C.H. Sotak, M. Fisher and J.D. Fenstermacher, Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia, Stroke 32, 1897-1905 (2001).
21. M.D. Silva, T. Omae, K.G. Helmer, F. Li, M. Fisher and C.H. Sotak, Separating changes in the intra- and extracellular water apparent diffusion coefficient following focal cerebral ischemia in the rat brain, Magn Reson. Med. 48, 826-837 (2002).
22. T.Q. Duong, J.V. Sehy, D.A. Yablonskiy, B.J. Snider, J.J. Ackerman and J.J. Neil, Extracellular apparent diffusion in rat brain, Magn Reson. Med. 45, 801-810 (2001).
23. T. Pearson and B.G. Frenguelli, Volume-regulated anion channels do not contribute extracellular adenosine during the hypoxic depression of excitatory synaptic transmission in area CA1 of rat hippocampus, Eur. J. Neurosci. 12, 3064-3066 (2000).
24. A. Biegon, M. Brewster, H. Degani, E. Pop, D. Somjen and A.M. Kaye, A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents., Cancer Res. 56, 4328-4331 (1996).
25. Y. Seki, P.J. Feustel, R.W. Keller, Jr, B.I. Tranmer and H.K. Kimelberg, Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokainate and an anion channel blocker, Stroke 30, 433-440 (1999).
26. H.K. Kimelberg, Cell volume in the CNS: Regulation and implications for nervous system function and pathology, The Neuroscientist 6, 13-24 (2000).
27. P.J. Feustel, Y. Jin, and H.K. Kimelberg, Volume regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke, in press (2004).
28. 3H]aspartate release from primary astrocyte cultures, Am. J. Physiol.:Cell Physiol. 274, C1511-C1520 (1998).
29. H.K. Kimelberg, P.J. Feustel, Y. Jin, J. Paquette, A. Boulos, R.W. Keller and B.I. Tranmer, Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion, Neuro Report 11, 2675-2679 (2000).
30. H.K. Kimelberg, Y. Jin and P.J. Feustel, Neuroprotective activity of tamoxifen in permanent focal ischemia, J. Neurosurgery 99, 138-142 (2003).
31. D.W. Choi, Excitotoxic cell death, J.Neurobiol. 23, 1261-1276 (1992).
32. M.D. Ginsberg, Neuroprotection in brain ischemia: an update I. The Neuroscientist 1, 95-103 (1995).
33. M.D. Ginsberg, Neuroprotection in brain ischemia: an update II. The Neuroscientist 1, 164-175 (1995).
34. M.D. Ginsberg, Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection. Tthe 2002 Thomas Willis lecture, Stroke 34, 214-223 (2003).
35. J.A. Hartings, M.L. Rolli, X.C. Lu and F.C. Tortella, Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection, J.Neurosci. 23, 11602-11610 (2003).
36. S.B. DeBow, D.L. Clark, C.L. MacLellan and F. Colbourne, Incomplete assessment of experimental cytoprotectants in rodent ischemia studies, Can. J. Neurol. Sci. 30, 368-374 (2003).
37. D.J. Gladstone, S.E. Black and A.M. Hakim, Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions, Stroke 33, 2123-2136 (2002).
38. N. Decher, H.J. Lang, B. Nilius, A. Bruggemann, A.E. Busch and K. Steinmeyer, DCPIB is a novel selective blocker of I(Cl,swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration, Br. J. Pharmacol 134, 1467-1479 (2001).
39. L.R. Nelson, E.L. Auen, R.S. Bourke, K.D. Barron, A.B. Malik, J. Cragoe, A.J. Popp, J.B. Waldman, H.K. Kimelberg, V.V. Foster, W. Creel and L. Schuster, Comparison of animal head injury models developed for treatment modality evaluation, in "Head Injury: Basic and Clinical Aspects" (R.G. Grossman and P.L. Gildenberg, Eds.), Raven Press, New York (1982).
40. R.S. Bourke, J.B. Waldman, H.K. Kimelberg, K.D. Barron, B.D. San Filippo, A.J. Popp and L.R. Nelson, Adenosine-stimulated astroglial swelling in cat cerebral cortex in vivo with total inhibition by a non-diuretic acylaryloxyacid derivative, J. Neurosurgery 55, 364-370 (1981).
41. S.H. Mehta, K.M. Dhandapani, L.M. De Sevilla, R.C. Webb, V.B. Mahesh and D.W. Brann, Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat, Neuroendocrinol. 77, 44-50 (2003).
42. J.I. MacGregor and V.C. Jordan, Basic Guide to the Mechanisms of Antiestrogen Action, Pharmacological Reviews 50, 151-196 (1998).
43. N.J. Alkayed, S. Goto, N. Sugo, H.D. Joh, J. Klaus, B.J. Crain, O. Bernard, R.J. Traystman and P.D. Hurn, Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke, J. Neurosci. 21, 7543-7550 (2001).
44. P.D. Hurn and L.M. Brass, Estrogen and stroke: a balanced analysis, Stroke 34, 338-341 (2003).
45. H. Wiseman, Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances, Trends Pharmacol Sci 15, 83-89 (1994).
46. K. Osuka, P.J. Feustel, A.A. Mongin, B.I. Tranmer and H.K. Kimelberg, Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat, J. Neurochem. 76, 1842-1850 (2001).